The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 15, 2020

Filed:

Apr. 25, 2018
Applicants:

Paul Gatenholm, Riner, VA (US);

Erdem Karabulut, Oslo, NO;

Inventors:

Paul Gatenholm, Riner, VA (US);

Erdem Karabulut, Oslo, NO;

Assignee:

CELLHEAL AS, Sandvika, NO;

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C09D 11/14 (2006.01); C09D 11/38 (2014.01); C09D 11/30 (2014.01); A61L 27/08 (2006.01); A61L 27/20 (2006.01); A61L 27/38 (2006.01); A61L 27/36 (2006.01); B33Y 70/00 (2020.01); B33Y 80/00 (2015.01); C09D 11/52 (2014.01); A61L 27/44 (2006.01); C09D 11/324 (2014.01); C12N 5/00 (2006.01); C09D 11/03 (2014.01); A61L 27/50 (2006.01); C12N 5/09 (2010.01); C12N 5/071 (2010.01); A61N 1/05 (2006.01); A61N 1/36 (2006.01); A61N 1/362 (2006.01); C12N 5/0793 (2010.01); C12N 5/077 (2010.01); C09D 11/037 (2014.01);
U.S. Cl.
CPC ...
C09D 11/14 (2013.01); A61L 27/08 (2013.01); A61L 27/20 (2013.01); A61L 27/36 (2013.01); A61L 27/367 (2013.01); A61L 27/3625 (2013.01); A61L 27/3675 (2013.01); A61L 27/3691 (2013.01); A61L 27/38 (2013.01); A61L 27/383 (2013.01); A61L 27/3826 (2013.01); A61L 27/3834 (2013.01); A61L 27/3873 (2013.01); A61L 27/3895 (2013.01); A61L 27/443 (2013.01); A61L 27/50 (2013.01); A61N 1/0536 (2013.01); A61N 1/362 (2013.01); A61N 1/3605 (2013.01); A61N 1/36067 (2013.01); A61N 1/36082 (2013.01); B33Y 70/00 (2014.12); B33Y 80/00 (2014.12); C09D 11/03 (2013.01); C09D 11/037 (2013.01); C09D 11/30 (2013.01); C09D 11/324 (2013.01); C09D 11/38 (2013.01); C09D 11/52 (2013.01); C12N 5/0062 (2013.01); C12N 5/0619 (2013.01); C12N 5/0657 (2013.01); C12N 5/0691 (2013.01); C12N 5/0693 (2013.01); C12N 5/0697 (2013.01); A61L 2300/412 (2013.01); A61L 2300/64 (2013.01); A61L 2400/12 (2013.01); A61L 2430/20 (2013.01); A61L 2430/32 (2013.01); C12N 2501/90 (2013.01); C12N 2501/999 (2013.01); C12N 2513/00 (2013.01); C12N 2533/78 (2013.01); C12N 2539/00 (2013.01);
Abstract

The present invention relates to preparation and use of nanocellulose fibrils or crystals such as disintegrated bacterial nanocellulose, tunicate-derived nanocellulose, or plant-derived nanocellulose, together with carbon nanotubes, as a biocompatible and conductive ink for 3D printing of electrically conductive patterns. Biocompatible conductive bioinks described in this invention were printed in the form of connected lines onto wet or dried nanocellulose films, bacterial cellulose membrane, or tunicate decellularized tissue. The devices were biocompatible and showed excellent mechanical properties and good electrical conductivity through printed lines (3.8·10S cm). Such scaffolds were used to culture neural cells. Neural cells attached selectively on the printed pattern and formed connective networks. The devices prepared by this invention are suited as bioassays to screen drugs against neurodegenerative diseases such as Alzheimer's and Parkinson's, study brain function, and/or be used to link the human brain with electronic and/or communication devices. They can also be implanted to replace neural tissue or stimulate guiding of neural cells. They can also be used to stimulate the heart by using electrical signaling or to repair myocardial infarction and/or damage related thereto.


Find Patent Forward Citations

Loading…